rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert Essner

Director

Company insider

Files Form 4 as: Director, Organon & Co; Director, Amicus Therapeutics; Chairman of the Board, Wyeth.

Every Form 4 they filed

In numbers

Trades disclosed
44
Buys
0
Sells
3
Bought
$0
Sold
$12.2M
Companies
3
Companies where not an officer
2
First trade
27 Jan 2006
Last trade
12 Jun 2026
Last filed
15 Jun 2026

Companies traded

Where they are an officer
WyethDirector, Officer · last 24 Apr 20080 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
OGN Organon & CoDirector · Pharmaceuticals · last 12 Jun 20260 buys · 0 sells
Amicus TherapeuticsDirector · last 10 Jun 20210 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Jun 2026filed 15 Jun 2026OGN Organon & Cooption or derivative · PharmaceuticalsSEC FORM 4 Code A$240K17,857.143 at $13.44filing
12 Jun 2026filed 15 Jun 2026OGN Organon & Cooption or derivative · PharmaceuticalsSEC FORM 4 Code A$240K17,857.14 at $13.44filing
13 Jun 2025filed 16 Jun 2025OGN Organon & Cooption or derivative · PharmaceuticalsSEC FORM 4 Code A$240K23,904.38 at $10.04filing
7 Jun 2024filed 11 Jun 2024OGN Organon & Cooption or derivative · PharmaceuticalsSEC FORM 4 Code A$200K9,638.55 at $20.75filing
9 Jun 2023filed 13 Jun 2023OGN Organon & Cooption or derivative · PharmaceuticalsSEC FORM 4 Code A$200K10,086 at $19.83filing
10 Jun 2022filed 14 Jun 2022OGN Organon & Cooption or derivative · PharmaceuticalsSEC FORM 4 Code A$200K5,640 at $35.46filing
10 Jun 2021filed 14 Jun 2021Amicus TherapeuticsSEC FORM 4 Code A—10,115 at $0.00filing
10 Jun 2021filed 14 Jun 2021Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—36,111 at $0.00filing
4 Jun 2021filed 8 Jun 2021OGN Organon & Cooption or derivative · PharmaceuticalsSEC FORM 4 Code A$316K8,772 at $36.05filing
4 Jun 2020filed 8 Jun 2020Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—18,574 at $0.00filing
4 Jun 2020filed 8 Jun 2020Amicus TherapeuticsSEC FORM 4 Code A—5,855 at $0.00filing
27 Jun 2019filed 1 Jul 2019Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—19,473 at $0.00filing
27 Jun 2019filed 1 Jul 2019Amicus TherapeuticsSEC FORM 4 Code A—6,250 at $0.00filing
7 Jun 2018filed 11 Jun 2018Amicus TherapeuticsSEC FORM 4 Code A—3,081 at $0.00filing
7 Jun 2018filed 11 Jun 2018Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—8,912 at $0.00filing
13 Jun 2017filed 15 Jun 2017Amicus TherapeuticsSEC FORM 4 Code A—5,814 at $0.00filing
13 Jun 2017filed 15 Jun 2017Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—16,236 at $0.00filing
9 Jun 2016filed 13 Jun 2016Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
10 Jun 2015filed 12 Jun 2015Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—20,000 at $0.00filing
12 Jun 2014filed 16 Jun 2014Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—15,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.